HAE: Haemonetics Corporation
Performance
HAE +72.92%
Watchlist
Select an item
Summary
HAE at a glance
HAE returned +72.92% over the past year and +9.62% a year over five years. Its worst drop in that year was -40.06%, smaller than 37% of stocks on Redstone, and its Sharpe ratio of 1.45 beats 91% of stocks on Redstone. It pays no dividends.
Current Drawdown
-7.23%
Rolling Volatility
31.04%
Actions
Metrics
Risk Indicators
Alpha56.72%
Beta0.28x
Sharpe1.45
Sortino2.65
Omega1.33
Calmar1.82
Martin3.04
Profile
About HAE
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital.
- Sector
- Health Care
- Industry
- Surgical & Medical Instruments & Apparatus
- Market cap
- $5.4B
- Listed
- May 1991
- Employees
- 3,009
- Headquarters
- Boston, MA
- Website
- haemonetics.com
Comparisons